Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi

ERJ Open Research Jan 2021, 7 (1) 00196-2020; DOI: 10.1183/23120541.00196-2020
The safety of cardioselective β₁-blockers in asthma: literature review and search of global pharmacovigilance safety reports
Miriam Bennett, Catherina L. Chang, Michael Tatley, Ruth Savage, Robert J. Hancox

ERJ Open Research Jan 2021, 7 (1) 00801-2020; DOI: 10.1183/23120541.00801-2020
Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
David M.G. Halpin, Claus F. Vogelmeier, Karen Mezzi, Pritam Gupta, Konstantinos Kostikas, Jadwiga A. Wedzicha

ERJ Open Research Jan 2021, 7 (1) 00816-2020; DOI: 10.1183/23120541.00816-2020
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
Richard W. Chapman, Michel R. Corboz, Carlos Fernandez, Eugene Sullivan, Andy Stautberg, Adam J. Plaunt, Donna M. Konicek, Vladimir Malinin, Zhili Li, David Cipolla, Walter Perkins

ERJ Open Research Jan 2021, 7 (1) 00592-2020; DOI: 10.1183/23120541.00592-2020
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Susannah J. King, Dominic Keating, Elyssa Williams, Eldho Paul, Brigitte M. Borg, Felicity Finlayson, Brenda M. Button, John W. Wilson, Tom Kotsimbos

ERJ Open Research Jan 2021, 7 (1) 00203-2020; DOI: 10.1183/23120541.00203-2020
First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
Alison Mackie, Juliane Rascher, Marion Schmid, Verena Endriss, Tobias Brand, Wolfgang Seibold

ERJ Open Research Jan 2021, 7 (1) 00447-2020; DOI: 10.1183/23120541.00447-2020
Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study
Jenny Genberg, Joanna M. Davies, Zainab Ahmadi, David Currow, Miriam J. Johnson, Hanan Tanash, Sabrina Bajwah, Magnus Ekström

ERJ Open Research Jan 2021, 7 (1) 00716-2020; DOI: 10.1183/23120541.00716-2020
ICS-formoterol reliever versus ICS and short-acting β₂-agonist reliever in asthma: a systematic review and meta-analysis
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley

ERJ Open Research Jan 2021, 7 (1) 00701-2020; DOI: 10.1183/23120541.00701-2020
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe

ERJ Open Research Jan 2021, 7 (1) 00394-2020; DOI: 10.1183/23120541.00394-2020
The six million dollar man
Mathilde Volpato, Stefan Nowak, Jean Luc Bourrain, Pascal Demoly, Engi Ahmed, Arnaud Bourdin, Jeremy Charriot

ERJ Open Research Jan 2021, 7 (1) 00341-2020; DOI: 10.1183/23120541.00341-2020

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us